Drug General Information
Drug ID	D0U6QC
Former ID	DNC002484
Drug Name	Porphobilinogen
Drug Type	Small molecular drug
Indication	Discovery agent		Phase 2	[521946]
Structure		Download 2D MOL 3D MOL
Formula	C10H14N2O4
Canonical SMILES	C1=C(C(=C(N1)CN)CC(=O)O)CCC(=O)O
InChI	1S/C10H14N2O4/c11-4-8-7(3-10(15)16)6(5-12-8)1-2-9(13)14/h5,12H,1-4,11H2,(H,13,14)(H,15,16)
InChIKey	QSHWIQZFGQKFMA-UHFFFAOYSA-N
CAS Number	CAS 487-90-1
PubChem Compound ID	1021
PubChem Substance ID	4184, 841796, 5237214, 7889721, 8144162, 8150930, 15220559, 24439377, 24898159, 46505854, 50366153, 57320674, 85088831, 92297630, 103061212, 103142282, 104296540, 117548282, 126523109, 129068198, 134223690, 134973155, 135366220, 137184304, 142077109, 152033842, 160965476, 162528766, 164764479, 176327367, 179293023, 184537504, 198960684, 226548162, 241081765, 250133589, 252356123, 252406251
Target and Pathway
Target(s)	Delta-aminolevulinic acid dehydratase	Target Info	Inhibitor	[551393]
BioCyc Pathway	Heme biosynthesis
	Tetrapyrrole biosynthesis
KEGG Pathway	Porphyrin and chlorophyll metabolism
	Metabolic pathways
PANTHER Pathway	Heme biosynthesis
PathWhiz Pathway	Porphyrin Metabolism
WikiPathways	Heme Biosynthesis
	Metabolism of porphyrins
References
Ref 521946	ClinicalTrials.gov (NCT00418795) Porphozym in the Treatment of Acute Attacks in AIP. U.S. National Institutes of Health.
Ref 551393	How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.